Chronic Japanese schistosomiasis and hepatocellular carcinoma : ten years of follow-up in Yamanashi Prefecture, Japan / Fumiyoshi Iida ... [et al.]
Other TitlesSchistosomiase japonaise chronique et carcinome hépatocellulaire : dix ans de suivi dans la préfecture de Yamanashi (Japon) : résumé
Esquistosomiasis japonesa crónica y carcinoma hepatocelular : diez años de seguimiento en la prefectura de Yamanashi (Japón) : resumen
Iida, Fumiyoshi, Iida, Ryuichi, Kamijo, Hiroshi, Takaso, Kazuhiko, Miyazaki, Yoshiki. et al. (1999). Chronic Japanese schistosomiasis and hepatocellular carcinoma : ten years of follow-up in Yamanashi Prefecture, Japan / Fumiyoshi Iida ... [et al.]. http://www.who.int/iris/handle/10665/56735
Bulletin of the World Health Organization : the International Journal of Public Health 1999 ; 77(7) : 573-581
DescriptionIn English with summary in French and Spanish
MetadataShow full item record
Showing items related by title and MeSH subject.
Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan. Iida, F.; Iida, R.; Kamijo, H.; Takaso, K.; Miyazaki, Y.; Funabashi, W.; Tsuchiya, K.; Matsumoto, Y. (1999)
Salem, A.K.; Abdulrab, A.; Alfakeh, Y.; Aown, A. (2012)We carried out a retrospective study of all patients admitted to Al-Thawra Teaching Hospital in Sana'a with hepatocellular carcinoma to study the disease profile in Yemeni patients and identify possible risk factors. During the 8-year study period, January 2001-December 2008, 251 patients were admitted with confirmed hepatocellular carcinoma. From hospital records we collected data on demographic characteristics, clinical manifestations, histological characters, viral markers, treatment and outcome. Around 75% of the patients were males. Age range ...
Evaluation of serum levels and significance of soluble CD40 ligand in screening patients with hepatitis C virus-related hepatocellular carcinoma Eltaher, S. M.; El Gil, R.; Fouad, N.; Mitwali, R.; El Kholy, H. (2016)The study's objective was to evaluate the clinical significance of sCD40L in HCV- associated hepatocellular carcinoma [HCV-HCC] patients. Sera concentration of circulating sCD40L and IL-10 were assayed using ELISA in 30 HCV positive patients with HCC, 30 HCV-positive patients with liver cirrhosis and 30 age-matched healthy volunteers with negative anti-HCV-Ab as a control group. Serum sCD40Lshowed statistically-significant high levels in HCV-HCC patients compared to HCV-cirrhotic patients and normal controls [P < 0.001]. Serum sCD40L had higher ...